Results 1 to 10 of about 13,224 (170)
Cancer & Metabolism, 2023 Background Bladder cancer (BLCA) research in Koreans is still lacking, especially in focusing on the prediction of BLCA. The current study aimed to discover metabolic signatures related to BLCA onset and confirm its potential as a biomarker.
Youngmin Han +7 more
doaj +2 more sources
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder [PDF]
Advances in Urology, 2012 Transitional cell carcinoma (TCC) of the bladder is one of the most common malignancies of genitourinary tract. Patients with bladder cancer need a life-long surveillance, directly due to the relatively high recurrence rate of this tumor.
Matteo Santoni +2 more
exaly +2 more sources
World Journal of Surgical Oncology, 2021 Background BLCA is a common cancer worldwide, and it is both aggressive and fatal. Immunotherapy (ICT) has achieved an excellent curative effect in BLCA; however, only some BLCA patients can benefit from ICT.
Haijun Yu, Yahua Zhong, Yu Haijun
exaly +2 more sources
BMC Cancer, 2023 Background Bladder urothelial carcinoma (BLCA) is the most common genitourinary cancer and the prognosis of patients is often poor. However, studies of basement membrane-related genes (BM-related genes) in BLCA are less reported.
Yanze Li +8 more
doaj +2 more sources
Biomolecules, 2022 The purpose of this study was to explore the relationship between bladder urothelial cancer (BLCA) and immunity, to screen prognosis-related immune genes (PIGs), and to construct an immune-related prognosis model (IRPM). We processed the relevant data of
Jiange Zhang +8 more
doaj +2 more sources
Identification of FLRT2 as a key prognostic gene through a comprehensive analysis of TMB and IRGPs in BLCA patients [PDF]
Frontiers in OncologyIntroductionThe tumor immune environment and immune-related genes are instrumental in the development, progression, and prognosis of bladder cancer (BLCA).
Ting Cai, Li Jinpeng
exaly +2 more sources
Discover OncologyBackground Bladder cancer (BLCA) represents one of the most prevalent malignant neoplasms within the urinary system, and its incidence is progressively rising annually in China.
Yuhui Zhao +7 more
doaj +2 more sources
Menin facilitates the cell proliferation of bladder cancer via modulating the TFAP2C/β-catenin axis
Genes and DiseasesBladder cancer (BLCA) is a common malignant tumor of the urinary system, with significant morbidity and mortality rates worldwide. The MEN1 gene, encoding the menin protein, plays a regulatory role in several cancers. However, the role played by menin in
Qing Shi +9 more
doaj +2 more sources
Construction and evaluation of a bladder cancer prognosis model based on super-enhancer-associated genes [PDF]
Discover OncologyIntroduction Bladder cancer (BLCA) is a malignant tumour that occurs on the mucosa of the bladder. It accounts for the first place in the incidence of genitourinary tumours in China.
Lieyu Xu +4 more
doaj +2 more sources
BLCA-RegMap portal: a co-regulatory influence network view of bladder cancer heterogeneity
, 2022 International audienceIntroduction: Bladder cancer studies performed in a variety of laboratories and by anumber of large-scale projects have given an unparalleled amount of information on tumors and in vitro models.
Pawlak, Geoffrey +4 more
core +7 more sources